Fundamental Data for OSUR

ORASURE TE(NSDQ:OSUR)

OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians'' offices, and workplace sites.

# Employees: 287

Address: 220 East First Street,Bethlehem,PA,USA

Phone: 610 882-1820

Fax: 610 814-2937

Website: www.orasure.com

Email: investorinfo@orasure.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Douglas A. Michels (Presi.; C.E.O.; Dir.)

Mark L. Kuna (Sr. V.P.; Fin.; Contr.)

Ronald H. Spair (C.F.O.; C.O.O.; Dir.)

Ronny B. Lancaster (Dir.)

Roger L. Pringle (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/10/2010

Mean EPS (Next Qtr): ($0.08)

Mean EPS (Year): ($0.12)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 4

Shares Performance

Period	OSUR	Compare to S&P
YTD	12.77 %	-6.67 %
4 Weeks	25.00 %	23.65 %
12 Weeks	55.43 %	46.54 %

Shares Information

Analyst Coverage: Y

Avg Volume: 168519

Shares Outstanding: 45M

Market Cap: $0.19B

52 Week High: $4.40

52 Week Low: $2.25

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 4/8/1987 OSUR split by factor of 3.000

Earnings Performance

EPS Growth in Last Quarter: 180.00 %

EPS Growth in Last Year: 200.00 %

Sales Growth in Last Quarter: 25.10 %

Sales Growth in Last Quarter: 28.17 %

Financials

Qtr Book Value: $1.80

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 2.600